Medium

Paul Fitzgerald

Paul Fitzgerald

·

Mar 31, 2024

It’s unfortunate but true: Antidepressants really aren’t all that effective.

I have for a long time quoted the results of the STAR*D clinical trial as evidence for why we need to invest in new treatments such as…

It’s unfortunate but true: Antidepressants really aren’t all that effective.

Paul Fitzgerald

·

Sep 3, 2021

Public funding of rTMS treatment in Australia: a long and winding road, to where?

Introduction

Public funding of rTMS treatment in Australia: a long and winding road, to where?

Paul Fitzgerald

·

Feb 26, 2021

Do we finally now know how all antidepressants work?

For decades many within and without of psychiatry have successfully propagated the notion that depression is caused by not enough of the…

Do we finally now know how all antidepressants work?

Paul Fitzgerald

·

Feb 23, 2021

rTMS Therapy and the dangers of flawed guideline development. An open letter to the RANZCP

For 20 years I have seen resistance to the development and uptake of repetitive Transcranial Magnetic Stimulation (rTMS) treatment in the…

rTMS Therapy and the dangers of flawed guideline development. An open letter to the RANZCP

Paul Fitzgerald

·

Aug 20, 2020

Innovative solutions are needed, not less lockdown, to protect the mental health of young people…

So apparently the University of Melbourne Vice Chancellor believes that Australia’s so-called “lockdown mindset” could be doing more harm…

Innovative solutions are needed, not less lockdown, to protect the mental health of young people…

Paul Fitzgerald

·

Aug 14, 2020

Why developing a vaccine may just well be the easiest step.

There will be serious societal challenges in COVID-19 vaccine implementation that we need to start addressing now.

Why developing a vaccine may just well be the easiest step.

Paul Fitzgerald

·

Aug 4, 2020

Mental Health consequences of lockdown are absolutely no reason to limit COVID related restrictions.

There is going to be profound mental health consequences, regardless of how we manage the COVID pandemic.

Mental Health consequences of lockdown are absolutely no reason to limit COVID related restrictions.

Paul Fitzgerald

·

Jun 15, 2020

What can we learn from the tortuous path to widespread clinical approval of the use of TMS therapy…

The development of transcranial magnetic stimulation (TMS) as a therapy for patients with a depression, has been one of the most important…

What can we learn from the tortuous path to widespread clinical approval of the use of TMS therapy…

Paul Fitzgerald

·

Jun 4, 2020

Ketamine — should we believe the hype?

It is really hard to underestimate the hype that has surrounded the development of ketamine as a potential antidepressant drug. In the…

Ketamine — should we believe the hype?

Paul Fitzgerald

·

May 27, 2020

The Challenges of Depression Treatment in 2020

Over recent years there has been a laudable and impressive effort to reduce the stigma associated with mental health conditions such as…

The Challenges of Depression Treatment in 2020

Paul Fitzgerald

Paul Fitzgerald

Paul Fitzgerald is a Professor of Psychiatry specializing in brain stimulation and neuroscience applications to depression, schizophrenia @ other disorders

Following

Help

Status

About

Careers

Press

Blog

Store

Privacy

Rules

Terms

Text to speech